The beta-blocker blood pressure drugs atenolol ( Tenormin), celiprolol, and talinolol. 阻滞剂类高血压药物阿替洛尔(天诺敏),塞利路尔和他林洛尔。
The addition of a well-tolerated beta-blocker to RAS blockade may improve hypertension treatment and quality of life in patients with diabetes. 在RAS阻断剂基础上加用一种耐受良好的β阻滞剂,可以增强降压疗效,改善糖尿病生活质量。
Sir James W Black, is a Scottish pharmacologist who invented beta-blocker and received the Nobel Prize for Medicine in1988 for his landmark discoveries. 詹姆斯.W。布莱克爵士是苏格兰著名的药学家,他发明的治疗高血压的乙型阻滞剂使他获得了1988年的诺贝尔医学奖。
The subjects were well-treated at baseline, said Carson, and spironolactone and beta-blocker use increased markedly during the study period. Carson说,这些受试者有良好的基础治疗,使用安体舒通和β受体阻滞剂在研究期间明显增加。
So atenolol is a beta-blocker but it's a different kind of beta-blocker than the one that we used in the clinical trial. 阿替洛尔虽然是β受体阻滞剂,但不是我们在临床试验中所证实过的β受体阻滞剂。
Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration 应用心脏再同步化治疗优化心衰和QRS持续时间延长患者的β阻断剂治疗
Early Beta-blocker Therapy for Patients with Acute Myocardial Infarction 急性心肌梗死患者早期β受体阻滞剂的应用
Conclusion: Beta-blocker therapy can reduce hospitalization days, re-hospitalization rate and mortality in DCM with CHF patients. It has favourable effect on cardiac function and prognosis. 结论:β-受体阻滞剂对治疗扩张型心肌病伴CHF有效,可降低扩心病CHF患者住院天数、再入院率及病死率,延缓心功能恶化。
Whether beta-blocker will benefit patients with class ⅳ cardiac function? Ⅳ级的重度心衰患者是否也能从β受体阻断药治疗中受益呢?
[ Conclusion] Patients routinely took antiplatelet drug and beta-blocker orally, the primary problem among which was that their dosage were low. [结论]抗血小板药物和β-受体阻滞剂使用率较好,存在主要问题是用量低,主要原因是随诊不够;
82 patients ( 70.7%) usually took beta-blocker orally; The diseases were usually misdiagnosed. 82例(70.7%)患者常规口服β-受体阻滞剂,心率达标率为39%;
Parallel study on treatment value and variety of heart rate variability after cardioselective beta-blocker, and non-cardioselective beta-blocker therapy in older patients with coronary artery disease 选择性与非选择性β受体阻滞剂对老年冠心病的治疗价值及对心率变异性影响的对比研究
The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension 噻嗪类利尿剂与β受体阻滞剂联合治疗高血压有致糖尿病的风险